Cargando…
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Many women with hormone receptor-positive early breast cancer can be managed effectively with endocrine therapies alone. However, additional systemic chemotherapy treatment is necessary for others. The clinical challenges in managing high-risk women are to identify existing and novel druggable targe...
Autores principales: | Bayani, Jane, Yao, Cindy Q., Quintayo, Mary Anne, Yan, Fu, Haider, Syed, D’Costa, Alister, Brookes, Cassandra L., van de Velde, Cornelis J. H., Hasenburg, Annette, Kieback, Dirk G., Markopoulos, Christos, Dirix, Luc, Seynaeve, Caroline, Rea, Daniel, Boutros, Paul C., Bartlett, John M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445616/ https://www.ncbi.nlm.nih.gov/pubmed/28649643 http://dx.doi.org/10.1038/s41523-016-0003-5 |
Ejemplares similares
-
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
por: Bartlett, J M S, et al.
Publicado: (2013) -
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
por: Bartlett, John M. S., et al.
Publicado: (2021) -
Pathway-based subnetworks enable cross-disease biomarker discovery
por: Haider, Syed, et al.
Publicado: (2018) -
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
por: Stephen, J, et al.
Publicado: (2014) -
A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial
por: Spears, Melanie, et al.
Publicado: (2016)